Loading Complete
Robert Albert Anders

Robert Albert Anders, MD, PhD

Pathology

Highlights

Languages

  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Robert Albert Anders

Primary Academic Title

Professor of Pathology

Background

Dr. Robert Albert Anders is an associate professor of pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. His clinical expertise includes pathology.

Dr. Anders received his M.D. from Mayo Clinic Medical School College of Medicine. He completed his residency in anatomic and clinical pathology and a fellowship in pathology from the University of Chicago Hospitals.

His research interests include gastrointestinal and liver pathology.

Additional Academic Titles

Professor of Oncology

Research Interests

Gastrointestinal and Liver Pathology, Liver cancer, Liver cell death and division

Lab Website

Robert Anders Lab - Lab Website

  • Dr. Anders' laboratory focuses on the basic processes that lead to cancer. His team approaches these questions through the use of both experimental models and examination of human tissues. His team is specifically interested in interrogating the immune microenvironment of cancer, detecting circulating cancer cells and preventing cancer metastasis.

Research Summary

Dr. Anders’ laboratory focuses on the basic processes that lead to liver cell death and division. His team approaches these questions through the use of both experimental models and examination of human tissues. His team is specifically interested in how the Hippo pathway controls the livers response to injury and malignant transformation. They have uncovered this pathway as a key mediator of hepatocyte and cholangiocyte biology.

Selected Publications

  • Kim AK, Gani F, Layman AJ, Besharati S, Zhu Q, Succaria F, Engle EL, Bhaijee F, Goggins MB, Llosa NJ, Pawlik TM, Yarchoan M, Jaffee EM, Simons HC, Taube JM, Anders RA. Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma. Cancer Immunol Res. 2019 May;7(5):805-812. doi: 10.1158/2326-6066.CIR-18-0499. Epub 2019 Mar 22. PMID: 30902819

  • Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA Jr. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. The New England journal of medicine. 2015 Jun 25;372(26):2509-20. Epub 2015 May 30. PMID: 26028255. PMCID: PMC4481136

  • Llosa NJ, Luber B, Siegel N, Awan AH, Oke T, Zhu Q, Bartlett BR, Aulakh LK, Thompson ED, Jaffee EM, Durham JN, Sears CL, Le DT, Diaz LA Jr, Pardoll DM, Wang H, Housseau F, Anders RA. Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy. Cancer Immunol Res. 2019 Oct;7(10):1574-1579. doi: 10.1158/2326-6066.CIR-18-0927. Epub 2019 Aug 22. PMID: 31439614 Free PMC article.

  • Taube JM, Anders RA, Young GD, Xu H, Sharma R, McMiller TL, Chen S, Klein AP, Pardoll DM, Topalian SL, Chen L. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Science Translational Medicine. 2012 Mar 28;4(127):127ra37. PMID: 22461641. PMCID: PMC3568523

  • Yarchoan M, Xing D, Luan L, Xu H, Sharma RB, Popovic A, Pawlik TM, Kim AK, Zhu Q, Jaffee EM, Taube JM, Anders RA. Characterization of the Immune Microenvironment in Hepatocellular Carcinoma. Clin Cancer Res. 2017 Dec 1;23(23):7333-7339. doi: 10.1158/1078-0432.CCR-17-0950. Epub 2017 Sep 19. PMID: 28928158

Locations

  1. The Johns Hopkins Hospital
    • 1800 Orleans Street, Baltimore, MD 21287

    Expertise

    Education

    University of Chicago Medicine

    Fellowship, Pathology, 2004

    University of Chicago Medicine

    Residency, Anatomic and Clinical Pathology, 2002

    Mayo Clinic

    Medical Education, MD PhD, 1998

    Board Certifications

    Clinical Pathology

    American Board of Pathology, 2002

    Anatomic Pathology

    American Board of Pathology, 2002

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)